Nasdaq GlobeNewswire

LifeSci Advisors’ Board Placement Initiative Announces Fifth Board Placement

Del

NEW YORK, 2016-11-04 15:00 CET (GLOBE NEWSWIRE) -- LifeSci Advisors, a leading life sciences-focused investor relations consultancy, announced today the fifth placement of a female executive to a life science company board, as part of their Board Placement Initiative (BPI), launched this year to match qualified female candidates with open seats on corporate boards of life sciences companies. Cynthia Smith, Chief Commercial Officer of ZS Pharma, Inc, a subsidiary of AstraZeneca, has joined the Board of Directors of Nivalis Therapeutics, a clinical stage pharmaceutical company focused on developing innovative solutions for people with cystic fibrosis (CF).  

Ms. Smith’s placement marks the fifth successful connection made by the program, with LifeSci Advisors looking to match many more candidates in the coming months. Ms. Smith is also one of the 20 recent graduates of Women In Bio’s Boardroom Ready Program, of which LifeSci Advisors is the founding sponsor.

“I am delighted to join the Nivalis team and look forward to contributing my experience and helping to further the company’s efforts to deliver promising therapeutic options for the cystic fibrosis community,” said Cynthia Smith. “I want to thank LifeSci Advisors and Women In Bio for providing additional networking and professional development opportunities to women eager to lend their talents to boards in our industry.”

Ms. Smith brings more than 20 years of experience to her new role. Since 2013, she has served as chief commercial officer and a member of the executive team of ZS Pharma, where she led efforts to transition the company from the development stage to a commercial enterprise. Prior to joining ZS Pharma, Ms. Smith held the position of Vice President, Market Access and Commercial Development at Affymax, Inc. Ms. Smith has also held various senior leadership positions in market access, corporate strategy, government relations and external affairs at Merck & Co. and served as a healthcare policy analyst in the White House Office of Management and Budget.

“Supporting outstanding female leaders like Ms. Smith and cultivating diversity on boards in the life sciences industry is at the core of our gender diversity work,” said Michael Rice, Founding Partner of LifeSci Advisors. “It is our hope that our own Board Placement Initiative and Women In Bio’s Boardroom Ready Program will continue to support women in our industry in overcoming barriers and make the life sciences industry a more diverse and inclusive space.”

“We are pleased to welcome Cynthia to the Nivalis Board of Directors. Her impressive industry experience, corporate leadership and commercialization expertise will be profound assets to our team,” said Jon Congleton, President and Chief Executive Officer of Nivalis Therapeutics. “We are delighted to have been introduced to Cynthia through LifeSci Advisors, and applaud their work in connecting board candidates with companies like ours.”

LifeSci Advisors’ BPI is accepting resumes from interested candidates on an ongoing basis. Resumes or open board seat positions can be sent to boarddiversity@lifesciadvisors.com.

About LifeSci Advisors, LLC
LifeSci Advisors, LLC (www.lifesciadvisors.com) is a unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. With a local presence in New York, Boston, Chicago, Philadelphia, London, Geneva and Tel Aviv, the firm provides the highest quality service for its clients through its deep sector specialization. Our roster of PhDs enables us to better understand our clients' R&D, regulatory, and commercial strategy, and our team of capital markets, investor relations, and public relations specialists help our clients effectively communicate to the marketplace. This combination of life sciences, capital markets, and investor relations competencies allows us to provide a valuable and highly differentiated service offering to our clients.

About Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. (http://www.nivalis.com) is a clinical-stage pharmaceutical company committed to the discovery, development and commercialization of therapeutics for people with CF. In addition to developing innovative solutions intended to extend and improve the lives of people with CF, Nivalis plans to utilize its proprietary GSNOR inhibitor portfolio to develop therapeutics for other diseases.

         Media Contact: Ann Kaiser
         The TASC Group
         Phone: 212-337-8870
         ann@thetascgroup.com

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Canadian Natural Resources Limited Announces 1 Billion Barrel Production Milestone at the Athabasca Oil Sands Project19.7.2018 11:00Pressemelding

CALGARY, Alberta, July 19, 2018 (GLOBE NEWSWIRE) -- Canadian Natural Resources Limited ("Canadian Natural"), as operator of the Jackpine and Muskeg River mines at the Athabasca Oil Sands Project ("AOSP"), is pleased to announce that the AOSP has achieved a mined production milestone of 1 billion barrels since operations began in 2003. Canadian Natural's President Tim McKay stated, "This is a significant milestone and demonstrates the size and scale of Canada's oil sands mining operations. The oil sands, through responsible development, provide sustainable long life low decline production and significant value for stakeholders. This milestone could not have been achieved without the dedication of the employees and contractors who focus on safe, reliable operations, while minimizing our environmental footprint to ensure long term sustainable development." Canadian Natural has a 70% working interest in the AOSP along with Chevron Canada Limited (20%) and Shell Canada Limited (10%). Canadi

ForgeRock Opens Up Open Banking19.7.2018 10:00Pressemelding

Delivers New, Open Reference Implementation and Sandbox Directory for Developers to Test Open Banking APIs in Five Minutes or Less LONDON, July 19, 2018 (GLOBE NEWSWIRE) -- ForgeRock®, the leading platform provider of digital identity management solutions, announced today the availability of the ForgeRock Open Banking Directory. Continuing its commitment to innovation and industry leadership, ForgeRock has delivered a reference bank implementation and directory, providing a technical sandbox for organizations looking to build and test Open Banking/PSD2 APIs. The lightweight and incredibly fast test platform has been acknowledged and celebrated by the team at UK Open Banking, the Implementation Entity set up by the UK Government's Competition and Markets Authority (CMA) in 2016, to deliver Open Banking. The ForgeRock development team has created an Open Banking Technical Solution Guide on the directory. Open Banking regulations, which began coming online in the UK earlier this year, for

TradeStation International Ltd to Offer Subscription Account Featuring TradeStation Technologies' Advanced Analytical Capabilities19.7.2018 10:00Pressemelding

LONDON, July 19, 2018 (GLOBE NEWSWIRE) -- TradeStation International Ltd, the London-based, United Kingdom subsidiary of TradeStation Group, Inc., today announced that it is now offering European traders, investors, advisors and market analysts access to TradeStation Analytics -- a non-brokerage subscription account featuring all of the advanced analytical capabilities of the TradeStation award-winning* platform. The software subscription account, which is provided to customers directly by affiliate TradeStation Technologies, Inc., offers market participants an opportunity to join the thousands of U.S.-based TradeStation subscribers - professionals and non-professionals alike - who trust TradeStation's cutting-edge technology to perform sophisticated market analysis, identify opportunities and stay one step ahead of today's rapidly changing financial markets. This TradeStation Analytics premium subscription package includes: Market Data delivered with speed, accuracy and reliability, w

Nordea Half-year Report 201819.7.2018 09:34Pressemelding

COPENHAGEN, Denmark, July 19, 2018 (GLOBE NEWSWIRE) -- Paris Stock Exchange : XHFT Second Quarter Results 2018 CEO Casper von Koskull's comments on the results: "This quarter we have started to see our efforts to increase customer satisfaction bearing fruit and we see signs of improving momentum across our various businesses among both corporate and household customers. We are delivering on cost, compliance, capital and credit quality, which is the foundation for continuing to be the stable, safe and trusted banking partner of our customers today and tomorrow. In recent years, Nordea has simplified and focused its business on its core Nordic markets and customers. The planned acquisition of Gjensidige Bank is a further step on that journey. It is a profitable, growing, digital bank, and together with our strategic partnership with Gjensidige, we are creating opportunities to strengthen our position in one of our core Nordic franchises and take part of a profitable growth. We have achie

Open-Silicon and Credo Demonstrate Solutions for Deep Learning and Networking Applications at TSMC OIP and Symposium in Amsterdam19.7.2018 09:00Pressemelding

AMSTERDAM, The Netherlands, July 19, 2018 (GLOBE NEWSWIRE) -- Open-Silicon, a system-optimized custom SoC solution provider and long-standing member of TSMC's Value Chain Aggregator (VCA) and Design Center Alliance (DCA) programs, and Credo, a global innovation leader in Serializer-Deserializer (SerDes) technology, will participate in a joint demonstration at the TSMC 2018 Open Innovation Platform Ecosystem Forum and Technology Symposium in Amsterdam, The Netherlands. These demonstrations will illustrate the capabilities of Open-Silicon's High Bandwidth Memory (HBM2) IP subsystem and Credo's 56G SerDes IP in enabling deep learning and networking applications. Visitors will also learn about other critical IP cores required for these applications, including a RISC-V based CPU subsystem, and Interlaken IP and Ethernet IP subsystems. Open-Silicon's HBM2 IP subsystem solution, in TSMC's FinFET and CoWoS® technologies, includes an HBM2 controller, PHY and interposer I/O. It's architected and

David Crosby Announces Intent to License His Name to the Cannabis Industry18.7.2018 18:04Pressemelding

Music industry icon pursuing licensing partnership with a leading Cannabis company LOS ANGELES and TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- David Crosby, co-founder of two of the most successful bands in history (Crosby, Stills, Nash & Young, and The Byrds) today announced he is seeking a licensing relationship with a national or global Cannabis company. This opportunity would include the exclusive license of his iconic name and marks for use worldwide. Mr. Crosby suggests calling the brand "MIGHTY CROZ" because his friends, colleagues and fans call him "Croz", but specific naming and packaging will be determined in consultation with the selected Cannabis company. Mr. Crosby will actively advise the selected Cannabis company in developing and marketing the brand. "People have been asking me to do a quality Cannabis brand and with legalization expanding, now is the right time," said David Crosby from his ranch in California. "Our first priority is partnering with a leading Cannabis co

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom